Need professional-grade analysis? Visit stockanalysis.com
$19.01B
11.51
13,184
2.57%
China Resources Double-Crane Pharmaceutical Co Ltd (600062) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY18.30, down 1.72% from the previous close.
Over the past year, 600062 has traded between a low of CNY17.92 and a high of CNY21.22. The stock has lost 0.1% over this period. It is currently 13.8% below its 52-week high.
China Resources Double-Crane Pharmaceutical Co Ltd has a market capitalization of $19.01B, with a price-to-earnings ratio of 11.51 and a dividend yield of 2.57%.
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.
Side-by-side comparison against top Healthcare peers.